Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line.

Diabetes - 1 Dec 1997

Wherrett D K, Singer S M, McDevitt H O

Abstract excerpt

Susceptibility to IDDM is strongly associated with major histocompatibility complex (MHC) class II genotypes. Nonobese diabetic (NOD) mice develop a similar autoimmune diabetes and have a unique MHC class II I-A allele that is required for the development of diabetes. A number of groups have shown that the introduction of resistant MHC class II alleles as transgenes into the NOD mouse protects from diabetes. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to B-Lymphocytes
Share to Diabetes Mellitus, Type 1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class II

Share to Mice, Transgenic

Share to Spleen

Share to T-Lymphocytes

Source

Identifiers

PMID: 9392482
DOI: 10.2337/diab.46.12.1970

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line.PMID 9392482Read ↗

Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.Semantic proximity Read ↗

Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.Semantic proximity Read ↗

I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.Semantic proximity Read ↗

NOD mice and autoimmunity.Semantic proximity Read ↗

Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.Semantic proximity Read ↗

The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.Semantic proximity Read ↗

Mouse Models of Autoimmune Diabetes: The Nonobese Diabetic (NOD) Mouse.Semantic proximity Read ↗

THE NOD MOUSE: A Model of Immune DysregulationSemantic proximity Read ↗

Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.Semantic proximity Read ↗

Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.Semantic proximity Read ↗

Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.Semantic proximity Read ↗

An update on the use of NOD mice to study autoimmune (Type 1) diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.